Build Accurate 3D Digital Twins for Biopharma Facilities in Minutes

Accelerate your biopharma facility design lifecycle by building high-fidelity 3D digital twins in minutes using a simple drag-and-drop interface. HakoBio's library of over 3,000 biopharma-specific assets (including bioreactors, chromatography skids, cleanroom partitions, utilities, and GMP-compliant equipment) enables you to construct an accurate spatial model of your manufacturing plant, cleanroom environment, and support areas. By creating a precise digital twin early in the conceptual design phase, you can visualize footprint constraints, evaluate equipment placement, and communicate effectively with engineering partners, all before investing in physical infrastructure.

Plan & Visualize Bioprocess Workflows in Space and Time

Optimize your bioprocess manufacturing operations by planning complex process units across both space and time within a unified digital environment. HakoBio's Process Configurator lets you define campaigns, schedule batch sequences, and map equipment utilization directly in your facility's digital twin. Integrated Gantt charts provide instant visibility into your production timeline, helping you identify bottlenecks, balance capacity across fermenters and downstream units, and maximize facility throughput. This data-driven approach to process planning ensures your biomanufacturing facility is configured for peak operational efficiency.

Simulate Personnel & Material Flow for Cleanroom Compliance

Ensure stringent cleanroom compliance by mapping and simulating the flow of personnel, raw materials, intermediates, finished product, and waste through your facility. HakoBio enables you to visualize dynamic material and personnel movement within your digital twin, identifying potential cross-contamination pathways before they occur. Use this data to strategically optimize cleanroom workflows, maintain strict material segregation, and validate your Contamination Control Strategy (CCS), ensuring your facility design aligns with global regulatory expectations, including EU GMP Annex 1 requirements.